Oncotarget

Research Papers:

5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme

Fabio Ciccarone, Elisabetta Valentini, Michele Zampieri and Paola Caiafa _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:24333-24347. https://doi.org/10.18632/oncotarget.4476

Metrics: PDF 2301 views  |   HTML 3118 views  |   ?  


Abstract

Fabio Ciccarone1, Elisabetta Valentini1, Michele Zampieri1 and Paola Caiafa1

1 Department of Cellular Biotechnologies and Hematology, “Sapienza” University of Rome and Pasteur Institute-Fondazione Cenci Bolognetti, Rome, Italy

Correspondence to:

Fabio Ciccarone, email:

Paola Caiafa, email:

Keywords: PARylation, TET1, 5hmC

Received: March 18, 2015 Accepted: May 30, 2015 Published: June 15, 2015

Abstract

5-hydroxymethylcytosine is a new epigenetic modification deriving from the oxidation of 5-methylcytosine by the TET hydroxylase enzymes. DNA hydroxymethylation drives DNA demethylation events and is involved in the control of gene expression. Deregulation of TET enzymes causes developmental defects and is associated with pathological conditions such as cancer. Little information thus far is available on the regulation of TET activity by post-translational modifications. Here we show that TET1 protein is able to interact with PARP-1/ARTD1 enzyme and is target of both noncovalent and covalent PARylation. In particular, we have demonstrated that the noncovalent binding of ADP-ribose polymers with TET1 catalytic domain decreases TET1 hydroxylase activity while the covalent PARylation stimulates TET1 enzyme. In addition, TET1 activates PARP-1/ARTD1 independently of DNA breaks. Collectively, our results highlight a complex interplay between PARylation and TET1 which may be helpful in coordinating the multiple biological roles played by 5-hydroxymethylcytosine and TET proteins.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4476